chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient experienced dizziness and fell twice; patient experienced dizziness and fell twice; slight fever of 99; This is a spontaneous report from a non-contactable consumer. An elderly male patient (reported as 65+ years) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 11Mar2021 (Batch/Lot number was not reported) as 2nd dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The day after the vaccination (on 12Mar2021), the patient experienced dizziness and fell twice. The patient also had a slight fever of 99. It was unknown if a treatment was given for the adverse events. It was also unknown if the patient had COVID prior to vaccination and unknown if the patient was tested for COVID post vaccination. The outcome of the events was recovered in Mar2021.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Arm swelled at injection site; Injection site appeared to leak fluid; This is a spontaneous report from a contactable consumer. A 31-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm on 11May2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021, the patient experienced arm swelled at injection site and appeared to leak fluid. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events arm swelled at injection site and appeared to leak fluid recovered on an unspecified date in May2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
cold began on 04Apr2022 and is ongoing and a little worse; getting a pretty bad cold; he felt that his nostrils were getting raw; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 74-year-old male patient received BNT162b2 (BNT162B2), on 01Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 74 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN, AE(s) following prior vaccinations: n/a), for Covid-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN, AE(s) following prior vaccinations: n/a), for Covid-19 Immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN, AE(s) following prior vaccinations: n/a), for Covid-19 Immunization. The following information was reported: NASOPHARYNGITIS (non-serious) with onset 04Apr2022, outcome "not recovered", described as "getting a pretty bad cold"; NASAL CONGESTION (non-serious) with onset 04Apr2022, outcome "unknown", described as "he felt that his nostrils were getting raw"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "cold began on 04Apr2022 and is ongoing and a little worse". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of nasopharyngitis, nasal congestion, condition aggravated.  Additional information: Reporter is asking on behalf of her husband who took a dose of the Pfizer Covid 19 vaccine last 01Apr2022, she further states that her husband started getting a pretty bad cold on 04Apr2022 and that he felt that his nostrils were getting raw. she states that the last shot he took was his 4th dose the vaccine. She also states that he took a home covid 19 test yesterday and that it turned out negative. She is asking if this has been previously reported, if the colds were caused by the vaccines, and if he should start taking antibiotics for the cold. She states the patient's cold began on 04Apr2022 and is ongoing and a little worse and he experienced his nostrils getting raw regarding his symptoms and this began in the evening on 04Apr2022 around 3:00pm to 4:00pm. She states the patient's card for his lot numbers, expiry dates, dates of administration and NDC numbers for his 1st, 2nd, 3rd and 4th doses of the covid vaccines is unavailable at this time and his card is not with him right now.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
After giving first Hep B shot, pt states "my heart beat was going very fast, my vision became blurred, it was like a dream. Next thing I remember was my grandmother shouting at me. Then I threw up". This happened about 30 minutes after shot given. Grandmother had him checked in ER. Given something for nausea/vomiting. Went to school in AM; no redness on injection site.
crescentic & sclerosing glomerulonephritis; This is a literature report for the following literature source(s):  A 30-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, Manufacturer Unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, Manufacturer Unknown), for COVID-19 immunization. The following information was reported: GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE (hospitalization, medically significant), 3 days after the suspect product(s) administration, outcome "recovering", described as "crescentic & sclerosing glomerulonephritis". The patient underwent the following laboratory tests and procedures: Antibody test: 25; cleared; Antineutrophil cytoplasmic antibody: Negative; Negative; Antinuclear antibody: Negative; Antiphospholipid antibodies: Negative; Biopsy kidney: crescentic and sclerosis glomerulonephritis; Blood pressure measurement: 175/103 mmHg, notes: On admission; Blood urea nitrogen/creatinine ratio: 16/1.5; Computerized tomogram: revealed left hydronephrosis, no nephrolithiasis, notes: or urothelial lesions; Cystoscopy: revealed left hydronephrosis, no nephrolithiasis, notes: or urothelial lesions; Double stranded DNA antibody: Negative; Hemoglobin: 13.3; Heart rate: 104, notes: Unit: per min. On admission; Immunology test: linear GBM staining; c3/c4 level: Negative; Several glomeruli showed segmental scars and, notes: fibrous crescents in addition to focal cellular crescents of varying ages raising the possibility of concurrent ANCA vasculitis; Negative; unremarkable; Renal function test: improved; Urine analysis: revealed dysmorphic RBCs and and proteinuria; White blood cell count: 16600. Therapeutic measures were taken as a result of glomerulonephritis rapidly progressive. Sender's Comments: Based on available information, the causal association between the event GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE and suspect drug BNT162b2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
This spontaneous report as received from a other health professional refers to patients of unknown age. In 2017 the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M040412 for prophylaxis. On 01-JAN-2017 the patients experienced incorrect product storage. No adverse event. Sender's Comments: US-009507513-1708USA011304: US-009507513-1708USA011305.
Shingrex Vaccine given 8/6/2021, the evening of 8/7/2021 noted some frequent itching on R shoulder/upper back which i didn't pay much attention to; upon waking 8/8/2021 noted 4.5 cm X 2 cm red raised rash with 2 vesicles on R shoulder and a 0.5cm raised rash with vesicle on posterior R shoulder associated with itching
Swelled armpits; Painful armpit/swelled armpits, painful; Not able to sleep; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. The following information was reported: SWELLING (non-serious) with onset 20May2021, outcome "unknown", described as "Swelled armpits"; AXILLARY PAIN (non-serious) with onset 20May2021, outcome "unknown", described as "Painful armpit/swelled armpits, painful "; INSOMNIA (non-serious) with onset 20May2021, outcome "unknown", described as "Not able to sleep". Therapeutic measures were not taken as a result of swelling, axillary pain, insomnia.  Additional information: The patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration on an unknown date. The patient did not have any allergies to medications, food, or other products. Concomitant medications included Pfizer vaccine taken within 4 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Information about lot/batch number has been requested.
Had febrile seizure on 11/11/07, was febrile following MMR vaccine admin. Also with rash to trunk
At our pharmacy, we are changing from giving Moderna to giving Pfizer vaccines.  We are still giving Moderna to our second dose patients and Pfizer to our first dose patients.  On our scheduler sheet it had her listed as first dose because she received her first Moderna dose at another facility.  The Technician that checked her in asked if it was her first dose and she said yes- she must have not understood him.  We did not have record of her first dose as it was at another facility so it was typed and filled as Pfizer.  The technician gave her the Pfizer vaccine and handed her the vaccine card.  At this point she told him she already had a card.  She gave him her card from the health department that said she had received Moderna for her first dose.  And we just gave her Pfizer for her second dose.
After vaccines, time frame unknown, patient would fuss, turn red, stop breathing, eyes roll back into head. Stopped breathing for approx. 1 minute then resume breathing.
Patient states symptoms appeared immediately after injection but postponed care.  States that the injection "hurt" and he has been unable to move his left arm above his head.  Report requested by provider.
Patient's right arm turned red and was hot to touch within 10 minutes of vaccine administration. Administered IM in the right arm and rechecked patient in 20 minutes.  Arm redness and warmth decreased, pt advised they could leave. Told them to put ice pack on the arm throughout today and tomorrow and to move arm around and massage the area.  Advised that if any other reaction occurs to call 911 if necessary
pt become very dizzy, almost passed out (her companion had passed out just moments before), probably due to anxiety and stress in situation, also warm in the area.  She was laid on ground and began to get color back in her face, dizziness went away after about 5 minutes, was assessed by EMT (since with companion who fainted), seemed to fine a few minutes later.
Felt bad after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt bad after vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination. Concurrent medical conditions included Fibroids and Hypercholesterolemia. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 20-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Nov-2021, the patient experienced FEELING ABNORMAL (Felt bad after vaccination). At the time of the report, FEELING ABNORMAL (Felt bad after vaccination) outcome was unknown. Concomitant medication also include some fibroid medication and cholesterol medication.No treatment information were provided.
Invasive pneumococcal disease 2/21/03. Prevnar administered 3 times on 8/6/02, 10/22/02, and 1/7/03. The medical record received on 2/18/04 states seizure, cough, congestion, fever, swelling of eye, runny nose and vomiting.
for doses 1 and 2 she had a sore muscle, a little touchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (for doses 1 and 2 she had a sore muscle, a little touchy) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 038K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (for doses 1 and 2 she had a sore muscle, a little touchy). At the time of the report, VACCINATION SITE PAIN (for doses 1 and 2 she had a sore muscle, a little touchy) outcome was unknown.            Concomitant medication: "a lot of medication".  No treatment medications were reported   This case was linked to MOD-2021-361527, MOD-2021-361528 (Patient Link).
I gave this child a DTAP #2, IPV #2, Hib #2 and pneumococcal #2 and within seconds the child's legs were red and it was moving downwards with swelling. Treated him with Benadryl (IM) 0.2 ml.
PATIENT CALLED THE PHARMACY TO REPORT PAIN IN HER ARM AFTER THE FIRST INJECTION. SHE SAYS THE PAIN STILL REMAINS AFTER 3 WEEKS. I ADVISED HER TO ICE THE ARM AND TAKE TYLENOL OR MOTRIN FOR THE PAIN.
MMRV (Proquad) was administered instead of just MMR.  Varicella was also administered at the visit.
Experienced normal symptoms of fatigue, headache, nausea for about 4 days after shot.  A week later (on April 23) had a large red rash aout 6 inches long and two inches wide on my left arm where I had received my injection.  Called Pharmacy where I had gotten my vaccine and told them.  He told me it was called Covid arm.  Went away in around 5 days.  A few days later, my lips became sore and red and I developed a cluster of blisters.  VERY painful.  They have gone away, but I still have a couple of red marks where the worst of the blisters erupted.  I did not get the second vaccine.
Swelling  of a baseball size below the site of injection, and heat at site of injection.   Lft arm is in a lot of pain can hardly lift my arm, took 800 Ibuprofen 04/04/2021 still swollen, heat, and in pain today 04/05/2021.   After about a half an hour I felt a numbness, not sure what that was all about, that is gone.
This spontaneous report was received from a medical assistant and refers to a 4 months old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 28-NOV-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 lot # M000592, expiration date 12-JAN-2017 (route of administration and anatomical location were not reported). No adverse events were reported.
a little bit of fever; aching; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 64-year-old female patient received BNT162b2 (BNT162B2), on 12Mar2021 as dose 1, single (Lot number: CJ1686) at the age of 62 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "a little bit of fever"; PAIN (non-serious), outcome "unknown", described as "aching".  Additional information: No Investigations were performed. It was reported that the patient received no other vaccines. Patient stated that with the first two vaccines she had the basic reactions of a little bit of fever and aching, took a nap never takes naps. The patient did not visit to ER or DR due to the events. Stated she is a 64-year-old athlete. It was reported that with the first two doses the symptoms only lasted about a day and Exact dates not provided.
felt cold including her lower back, knees and shoulders; Very short of breath; Her joints hurt badly; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (felt cold including her lower back, knees and shoulders), DYSPNOEA (Very short of breath) and ARTHRALGIA (Her joints hurt badly) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     Concurrent medical conditions included No adverse event (no medical history reported).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING COLD (felt cold including her lower back, knees and shoulders), DYSPNOEA (Very short of breath) and ARTHRALGIA (Her joints hurt badly). At the time of the report, FEELING COLD (felt cold including her lower back, knees and shoulders), DYSPNOEA (Very short of breath) and ARTHRALGIA (Her joints hurt badly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
it was red; (It was) very itchy & It has gotten worse; (It was) hot; Hard knot at the injection site & it was raised & It has gotten worse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH ((It was) hot), VACCINATION SITE INDURATION (Hard knot at the injection site & it was raised & It has gotten worse), VACCINATION SITE PRURITUS ((It was) very itchy & It has gotten worse) and VACCINATION SITE ERYTHEMA (it was red) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C71A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced VACCINATION SITE INDURATION (Hard knot at the injection site & it was raised & It has gotten worse). On 10-Jun-2021, the patient experienced VACCINATION SITE WARMTH ((It was) hot) and VACCINATION SITE PRURITUS ((It was) very itchy & It has gotten worse). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (it was red). At the time of the report, VACCINATION SITE WARMTH ((It was) hot), VACCINATION SITE INDURATION (Hard knot at the injection site & it was raised & It has gotten worse), VACCINATION SITE PRURITUS ((It was) very itchy & It has gotten worse) and VACCINATION SITE ERYTHEMA (it was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported. Treatment medication was not provided.
From the day of the shot there was some soreness that I thought was normal. However, within a few days the pain had progressed into shooting pain down my arm with pulsating pain when at rest. At two weeks the pain had progressed and was causing me to wake up at night and causing me difficulty in turning over. The pain has increased over the last three months. When at rest it still hurts and during the night I often have to lift the sore arm with my other hand in order to turn over to my other side.  The pain experience is much worse when I cross my arm over my body or when lifting out to the side making it difficult to perform normal lifting task at work.
covid-19; fever; flu symptoms; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced COVID-19 (covid-19).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
WITHING 5 MINUTES FOLLOWING VACCCINATION PATIENT SLUMPED IN HER CHAIR AND FATHER REPORTED A MILD SEIZURE. PATIENT WAS CONCIOUS AND RESPONSIVE TO QUESTIONS UNTIL PARAMEDICS ARRIVED.
Onset of L shoulder pain over the course of several days following injection and progressive over several weeks. 3weeks after injection, evaluated of orthopedic surgeon and diagnosed with subacromial bursitis and early "frozen shoulder". Treated with steroid injection and physical therapy.  Continued to worsen....3-4months after injection pain was resolving per employee. She did not request time off work or restriction.
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Lack of Range of Motion-Severe, Systemic: Joint Pain-Severe, Additional Details: Patient had his Pfizer booster on 2/27/22. He reported his vaccine adverse reaction on 4/3/22. Patient stated his shoulder was "messed up" after receiving his vaccine at pharmacy. His shoulder is in a lot of pain and he has a lack of range of motion for the shoulder. Patient went to his PCP and was told by the PCP that this pain was due to the vaccine administration. His PCP diagnosed it as Bursitis and referred him to an orthopedic surgeon. Patient would like a call back from someone at corporate.
G1P0100 received vaccine at 31 3/7 EGA. Next day noted decreased fetal movement, which continued. Evaluated on 10/24/21, found to have intrauterine fetal demise.
get a flu shot every year; Initial information regarding an unsolicited valid non-serious social media case received from non-healthcare professional (patients husband) on 22-Nov-2020.  This case involved female patient (age not reported) who got flu shot every year (Influenza) when received INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concurrent condition, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site prophylactic vaccination.  On an unknown date it was reported that, the patient got flu shot every year (Influenza) (unknown latency) following the administration of INFLUENZA VACCINE.   Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was unknown.  There will be no information available on the batch number for this case.
2-3 cm red allergic rxn. Loratadine 10 mg q hr x 7 days. Ibuprofen 600 mg TID x 10 days.
Mother called stating child developed redness, swelling at shot site on 9/9/04, blotchy rash on upper arm started 9/14/04. Mother then called to say father had sprayed child with dermaplast on 9/14/04 and then rash appeared. On 9/15/04 mother said rash subsided.